ASX - By Stock
|
PAA |
Re:
Ann: Demonstration batch of smaller size MPL tablets completed
|
|
kpax
|
52 |
11K |
19 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
52
|
11K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Demonstration batch of smaller size MPL tablets completed
|
|
kpax
|
52 |
11K |
27 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
52
|
11K
|
27
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
10 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
1.4K
|
377K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
23 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
1.4K
|
377K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Phase 3 Canines Lymphoma B Trial ( what to expect)
|
|
kpax
|
98 |
21K |
29 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
98
|
21K
|
29
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
40 |
27/11/21 |
27/11/21 |
ASX - By Stock
|
1.4K
|
377K
|
40
|
|
ASX - By Stock
|
C6C |
Re:
Ann: Copper Mountain Mining Announces Q3 2021 Financial Results
|
|
kpax
|
20 |
6.6K |
7 |
14/11/21 |
14/11/21 |
ASX - By Stock
|
20
|
6.6K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Monsoon Presentation
|
|
kpax
|
72 |
14K |
34 |
13/11/21 |
13/11/21 |
ASX - By Stock
|
72
|
14K
|
34
|
|
ASX - By Stock
|
PAA Biotech |
Re:
AGM Voting 2021
|
|
kpax
|
27 |
5.8K |
9 |
20/10/21 |
20/10/21 |
ASX - By Stock
|
27
|
5.8K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Phase 3 Canines Lymphoma B Trial ( what to expect)
|
|
kpax
|
98 |
21K |
15 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
98
|
21K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Phase 3 Canines Lymphoma B Trial ( what to expect)
|
|
kpax
|
98 |
21K |
21 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
98
|
21K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Following Extension of Survival, PAA Prepares Phase 3 Trial
|
|
kpax
|
68 |
16K |
40 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
68
|
16K
|
40
|
|
ASX - By Stock
|
BRU |
Re:
The Main Game..
|
|
kpax
|
267 |
70K |
29 |
15/10/21 |
15/10/21 |
ASX - By Stock
|
267
|
70K
|
29
|
|
ASX - By Stock
|
PAA |
Re:
AGM Shareholder Questions
|
|
kpax
|
42 |
6.4K |
16 |
27/09/21 |
27/09/21 |
ASX - By Stock
|
42
|
6.4K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
AGM Shareholder Questions
|
|
kpax
|
42 |
6.4K |
14 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
42
|
6.4K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
AGM Shareholder Questions
|
|
kpax
|
42 |
6.4K |
24 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
42
|
6.4K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
The Home Stretch
|
|
kpax
|
360 |
82K |
15 |
19/09/21 |
19/09/21 |
ASX - By Stock
|
360
|
82K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
The Home Stretch
|
|
kpax
|
360 |
82K |
18 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
360
|
82K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
The Home Stretch
|
|
kpax
|
360 |
82K |
14 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
360
|
82K
|
14
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
kpax
|
2.1K |
635K |
17 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
2.1K
|
635K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
mTOR Signalling
|
|
kpax
|
10 |
2.3K |
8 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
10
|
2.3K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
mTOR Signalling
|
|
kpax
|
10 |
2.3K |
24 |
13/09/21 |
13/09/21 |
ASX - By Stock
|
10
|
2.3K
|
24
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
kpax
|
2.1K |
635K |
18 |
13/09/21 |
13/09/21 |
ASX - By Stock
|
2.1K
|
635K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Broker Briefing Investor Webinar
|
|
kpax
|
8 |
2.8K |
11 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
8
|
2.8K
|
11
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
kpax
|
2.1K |
635K |
25 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
2.1K
|
635K
|
25
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Change of Director's Interest Notice - Jane Bell
|
|
kpax
|
5 |
1.8K |
7 |
06/09/21 |
06/09/21 |
ASX - By Stock
|
5
|
1.8K
|
7
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
kpax
|
2.1K |
635K |
7 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
2.1K
|
635K
|
7
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
kpax
|
2.1K |
635K |
4 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
2.1K
|
635K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Appendix 4E
|
|
kpax
|
35 |
8.2K |
7 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
35
|
8.2K
|
7
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Appendix 4E
|
|
kpax
|
35 |
8.2K |
4 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
35
|
8.2K
|
4
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
kpax
|
2.1K |
635K |
17 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
2.1K
|
635K
|
17
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
kpax
|
2.1K |
635K |
3 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
2.1K
|
635K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Oral Treatment for Covid 19, Human Phase I Trials
|
|
kpax
|
132 |
28K |
10 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
132
|
28K
|
10
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
kpax
|
2.1K |
635K |
31 |
30/08/21 |
30/08/21 |
ASX - By Stock
|
2.1K
|
635K
|
31
|
|
ASX - By Stock
|
PAA |
Re:
Limping Home
|
|
kpax
|
32 |
5.9K |
19 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
32
|
5.9K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4E & Full Year Statutory Accounts
|
|
kpax
|
16 |
3.5K |
18 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
16
|
3.5K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Phase 3 Canines Lymphoma B Trial ( what to expect)
|
|
kpax
|
98 |
21K |
20 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
98
|
21K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Phase 3 Canines Lymphoma B Trial ( what to expect)
|
|
kpax
|
98 |
21K |
8 |
15/08/21 |
15/08/21 |
ASX - By Stock
|
98
|
21K
|
8
|
|
ASX - By Stock
|
PAA |
Phase 3 Canines Lymphoma B Trial ( what to expect)
|
|
kpax
|
98 |
21K |
37 |
14/08/21 |
14/08/21 |
ASX - By Stock
|
98
|
21K
|
37
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Oral Treatment for Covid 19, Human Phase I Trials
|
|
kpax
|
132 |
28K |
29 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
132
|
28K
|
29
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Oral Treatment for Covid 19, Human Phase I Trials
|
|
kpax
|
132 |
28K |
18 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
132
|
28K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Oral Treatment for Covid 19, Human Phase I Trials
|
|
kpax
|
132 |
28K |
17 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
132
|
28K
|
17
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Oral Treatment for Covid 19, Human Phase I Trials
|
|
kpax
|
132 |
28K |
22 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
132
|
28K
|
22
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Oral Treatment for Covid 19, Human Phase I Trials
|
|
kpax
|
132 |
28K |
15 |
09/08/21 |
09/08/21 |
ASX - By Stock
|
132
|
28K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem Completes Build of OHD Benchtop Flow Reactor
|
|
kpax
|
53 |
10K |
12 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
53
|
10K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Virtual Investor Briefing
|
|
kpax
|
73 |
16K |
25 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
73
|
16K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
kpax
|
197 |
35K |
11 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
197
|
35K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
kpax
|
197 |
35K |
18 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
197
|
35K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
kpax
|
197 |
35K |
48 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
197
|
35K
|
48
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust files patent for monepantel in viral diseases
|
|
kpax
|
48 |
9.5K |
20 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
48
|
9.5K
|
20
|
|